Immunovant Stock Up 30% as Investor Trims Stake by $3 Million, But Here's Why It Still Seems Bullish [Yahoo! Finance]
Immunovant, Inc. (IMVT)
Company Research
Source: Yahoo! Finance
On February 17, 2026, Alpine Global Management disclosed a sale of 127,039 shares of Immunovant (NASDAQ:IMVT) , with an estimated transaction value of $2.83 million based on quarterly average pricing. What happened According to a filing with the Securities and Exchange Commission dated February 17, 2026, Alpine Global Management reduced its position in Immunovant by 127,039 shares during the fourth quarter of 2025. The estimated transaction value was $2.83 million, calculated using the quarterly average share price. The fund's quarter-end valuation for this position decreased by $22.36 million, a figure that includes both trading activity and market price movements. What else to know This was a sale, leaving Immunovant at 11.4% of Alpine's 13F AUM after the quarter. Top holdings after the filing: NASDAQ:IMVT: $66.77 million (12.5% of AUM) NASDAQ:RIVN: $51.80 million (9.7% of AUM) NYSE:ACHR: $35.17 million (6.6% of AUM) NYSE:CVNA: $18.82 million (3.5% of AUM) NYSE:
Show less
Read more
Impact Snapshot
Event Time:
IMVT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMVT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMVT alerts
High impacting Immunovant, Inc. news events
Weekly update
A roundup of the hottest topics
IMVT
News
- Immunovant (IMVT) is now covered by Sanford C. Bernstein. They set a "market perform" rating and a $28.00 price target on the stock.MarketBeat
- Assessing Immunovant (IMVT) Valuation After Recent Share Price Weakness [Yahoo! Finance]Yahoo! Finance
- Immunovant, Inc. (IMVT) Analysts Raise Price Targets Following Q3 Earnings Update [Yahoo! Finance]Yahoo! Finance
- Assessing Immunovant (IMVT) Valuation As Shares Deliver A 25% One Year Return [Yahoo! Finance]Yahoo! Finance
- SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Immunovant, Inc. (NASDAQ: IMVT)PR Newswire
IMVT
Earnings
- 2/6/26 - Beat
IMVT
Sec Filings
- 3/20/26 - Form 4
- 2/27/26 - Form 4
- 2/10/26 - Form 144
- IMVT's page on the SEC website